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Proteinuria

Goni Katz-Greenberg, MD
Transplant Nephrology Fellow

Outline and objectives

DEFINITION

SCREENING/
MEASUREMENT

ETIOLOGY

TREATMENT

Definition of Proteinuria
• Normal protein excretion < 150mg daily
• Normal albumin excretion < 30mg daily
• Moderately increased albuminuria 30-299mg daily (formerly
microalbuminuria) over 3-6 months*
• Severely increased albuminuria > 300mg daily (formerly
macroalbuminuria)
• Nephrotic range proteinuria > 3.5 grams daily

Measurement of Proteinuria
• Albumin excretion above 300
mg/day is considered overt
albuminuria à the level at
which the standard dipstick
becomes positive
• Dipstick – ALBUMIN
• 24-hour urine test - gold
standard, but cumbersome
• Urine protein:creatinine
ratio/ spot ratio

24-hour urine collection
• The gold standard for measurement of protein excretion is
a 24-hour urine collection (normal value <150 mg/day).
• Adults under the age of 50 years, daily creatinine excretion
should be
• 20 to 25 mg/kg of lean body weight in men
• 15 to 20 mg/kg of lean body weight in women

• From the ages of 50 to 90 years, there is a progressive 50%
decline in creatinine excretion due primarily to a fall in
muscle mass

UPCR
• UPCR best done as spot first- or second-morning urine
sample after avoiding exercise
• It is a RATIO, and is best when done in a steady state
• Individuals with large muscle mass, the UPCR (or UACR)
will underestimate proteinuria
• In cachectic/small muscle mass patients, the UPCR (or
UACR) will overestimate proteinuria

Case 1
Mr. Jones is a 69 years old male who comes to clinic
complaining of increased abdominal girth and leg swelling for
the past 4 weeks. His other PMHx is significant for HTN and
hyperlipidemia.
Physical exam •
•
•
•
•
•
•

Temperature 37.2C (98.9)
BP 135/68, HR 85
HEENT – WNL
Chest – clear to auscultation
Heart – S1S2, no murmurs or gallops
Abdomen – distended, non tender
LEs – Edema +3 bilaterally, to hip level

Case 1 – Cont’d – Differential Diagnosis
•
•
•
•

Nephrotic Syndrome
Cirrhosis
Heart failure
Myxedema

Case 1 – Cont’d – Work up
•
•
•
•
•
•

Albumin
BUN, creatinine
Urinalysis
24-hour urine protein/ UPCR in random sample
Serum LDL and cholesterol
Albumin
2.8g/dL
LFTs ?
Creatinine
1.1mg/dL
BUN

25

Urinalysis

+ 4 protein, with
oval fat bodies seen.
Few RBC, no casts.

UPCR

8.5g/g

T. chol

310 mg/dL

Nephrotic Syndrome
• Urine protein exertion of >
3.5 gram/ 24 hours (or UPCR
of > 3000mg/g)
• Hypoalbuminemia < 3.0 g/dL
• Edema
• Hyperlipidemia +/- Lipidiuria

Where is the proteinuria coming from?

Types of Proteinuria
Proteinuria
Classification

Pathogenesis

Clinical Setting

Level of
proteinuria

Glomerular

Increased filtration of
macromolecules (albumin)

Primary or systemic
diseases

Variable

Overflow

Increased filtration
(causing decreased
reabsorptive capacity) or
marked overproduction

Myeloma, hemolysis,
rhabdomyolysis

Variable

Tubulointerstitial

Increased excretion of low
molecular weight proteins
(B2 macroglobulin) from
decreased proximal tubule
absorption

Interstitial
inflammation/injury,
heavy metal
intoxication

<3 gr/day

Post-Renal
Proteinuria

Inflammation of urinary
UTI’s, nephrolithiasis,
tract. Non-albumin protein GU tumor

<1 gr/day

Back to Mr Jones…
Next steps of work up
•
•
•
•
•
•

HbA1C
Anti-PLA2R autoantibody
ANA and dsDNA antibody
Serum C3 and C4 levels
HBV, HCV, HIV
In patients older than 50
years – serum free light
chains and serum
protein immunofixation

àKIDNEY BIOPSY

Nephrotic Syndrome - DD
Systemic Diseases
• Diabetes Mellitus
• Lupus Nephritis
• Amyloidosis
Primary Diseases of the Kidney
• Membranous Nephropathy
• Minimal Change Disease
• Focal Segmental Glomerulosclerosis (FSGS)

Kidney Biopsy

Membranous Nephropathy

Kidney Biopsy from a different story

An S. De Vriese.. Richard J. Glassock, and Fernando C. Fervenza Differentiating Primary,
Genetic, and Secondary FSGS in Adults: A Clinicopathologic Approach.
J Am Soc Nephrol 29: 759–774, 2018

Membranous Nephropathy

About 70%–80% of membranous nephropathy are classified
as primary

The remaining 20-30% have secondary forms associated
with autoimmune diseases, infections, drug exposure, or
malignancy

Identification of the two target antigens PLA2R and
THSD7A allowed the development of serologic tests for
circulating anti-PLA2R or anti-THSD7A autoantibodies,
and revolutionized the diagnosis and follow up

Cancer Screening

Standard cancer screening is recommended
in all patients with glomerular lesions which
may be associated with malignancy
Targeted screening tests must be
additionally performed according to each
patient’s specific risk factors for cancer

Routine and targeted cancer screening in patients with
glomerulopathy
The picture can't be displayed.

Thromboembolism
Patients with the nephrotic syndrome are at increased risk for
venous thrombosis, particularly deep vein thrombosis and renal
vein thrombosis

There is also increased risk of arterial thrombosis and pulmonary
emboli

The risk of thrombosis is inversely related to the serum albumin
levels

When? Albumin < 2.5 g/dL

Prophylactic anticoagulation?

Who?
•Membranous Nephropathy
•Pregnant patients

Proteinuria without Nephrotic Syndrome
• Isolated proteinuria?
•
•
•
•

No
No
No
No

HTN
hematuria
systemic disease
kidney injury/ azotemia

Transient Proteinuria
• Common, especially in young individuals
• Causes: fever, exercise, acute illness (eg URI),
hyperglycemia
• Usually < 1 gram/ day
• Test: UACR or UPCR over 1-3 months
• Avoid exercise 24-48 hours prior to test
• Diagnosis is made when repeat test is no longer positive for
proteinuria

Orthostatic Proteinuria
• Increased protein excretion in the upright position but
normal protein excretion when the patient is supine
• Relatively common in adolescents (up to 5%), but
uncommon in adults > 30 years old
• Usually < 1 gram/ day
• Benign, but kidney function and proteinuria should be
followed yearly
• NORMAL early morning sample (<30mg), with positive PM
sample within 24 hours = orthostatic proteinuria

Nephritic Syndrome
à Glomerular Inflammation
• Hematuria
• Proteinuria – can be in the nephrotic range
• HTN
• Kidney injury
• Involvement of other organs

Nephritic Syndrome - DD
Systemic
•
•
•
•
•

ANCA vasculitis (pauci-immue glomerulonephritis)
Anti-GBM disease
SLE
IgA nephropathy
TMA

Infections
• Bacterial – Strep/ staph
• Viral – HBV, HCV, CMV
• Parasitic – Plasmodium malariae

Proteinuria - What is the big deal?
• The degree of proteinuria is prognostically important in
patients with primary and secondary glomerular diseases
• Higher degrees of proteinuria are associated with a more
rapid progression to kidney failure, even in the absence of
nephrotic syndrome

Relative risks of Major Complications of CKD

Treatment
Optimal HTN control: Aim BP < 130/80
Add a diuretic for optimal HTN management
ACEi/ARB
Other agents that reduce proteinuria: non-dihydropyridine
Ca Channel blockers, mineralocorticoid antagonists
• SLGT-2 inh
•
•
•
•

• Treatment for glomerular disease - IS

ACEi and ARB Therapy
• MDRD study (Annals Int Med,
1995)
• Proteinuria is independent risk
factor for CKD progression
• Tight BP control reduces
proteinuria and reduces GFR
decline

Mechanism of ACE-inhibitors

Spironolactone/Eplerenone
• Metanalysis (CJASN 2009) looked at MCA (Spironolactone 25mg
daily) with ACEi compared to ACEi alone
• Proteinuria and HTN control improved significantly more with
MCA + ACEi group
• No difference in GFR preservation between groups
• Higher risk Hyperkalemia with MCA+ACEi

SLGT-2 inhibitors

• CREDENCE trial (NEJM 2019) double blind randomized trial,
type II DM + albuminuria +CKD
• Canagliflozin 100mg daily or placebo
• All patients GFR 30-90, treated with RAAS blockade
• Diabetic patients with >300mg albuminuria despite
ARB/ACEi should start a sodium-glucose co-transporter
(SGLT-2inh)

SLGT-2 inhibitors

Take home message
• Even within the normal range, higher amounts of
albuminuria are associated with an increased risk of
cardiovascular disease
• For patients who are very likely to have nephrotic-range
proteinuria due to diabetic nephropathy, biopsy can be
deferred

• Treat underlying cause/risk factors:
obesity/DM/HTN/smoking/HL

Take home message - 2
• Start RAAS blockade: don’t wait! can start in CKDG1G3b safely. Expect 30% rise in creat which stabilizes
• With treatment, aim to reduce albuminuria as much as
possible by up-titrating RAAS blockade to achieve maximum
effect to delay CKD progression
• For type 2 DM, with eGFR > 45, and > 300mg albuminuria,
NOT on insulin/sulfynurea, START SGLT-2 inh at lowest
dose. Expect 30% rise in creatinine which stabilizes

Thank you!
• Questions?

